Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMEDNYSE:CDI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMEDAmedisys$95.42+0.1%$93.04$82.15▼$98.95$3.13B0.96413,394 shs393,384 shsCDICDI$8.22$0.00$4.84▼$9.65N/AN/A81,650 shsN/A13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMEDAmedisys+0.06%-0.86%+4.27%+3.13%-0.08%CDICDI0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMEDAmedisys2.9554 of 5 stars1.12.00.05.03.01.71.3CDICDIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMEDAmedisys 2.20Hold$100.755.59% UpsideCDICDI 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest DP3D, AMED, CDI, and DP2D Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/16/2025AMEDAmedisysRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.003/4/2025AMEDAmedisysStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$101.00 ➝ $101.00(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMEDAmedisys$2.37B1.32$6.45 per share14.80$34.31 per share2.78CDICDIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMEDAmedisys-$9.75M$2.7137.8719.711.783.57%12.20%6.74%7/23/2025 (Estimated)CDICDIN/AN/A0.00∞N/AN/AN/AN/AN/ALatest DP3D, AMED, CDI, and DP2D EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/23/2025Q1 2025AMEDAmedisys$1.13$1.25+$0.12$1.84$597.43 million$594.78 million2/26/2025Q4 2024AMEDAmedisys$1.05$0.96-$0.09-$0.62$602.38 million$598.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMEDAmedisysN/AN/AN/AN/AN/ACDICDIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMEDAmedisys0.051.191.19CDICDIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMEDAmedisys94.36%CDICDI35.88%Insider OwnershipCompanyInsider OwnershipAMEDAmedisys2.10%CDICDI8.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMEDAmedisys20,00032.82 million32.07 millionOptionableCDICDIN/AN/AN/ANot OptionableDP3D, AMED, CDI, and DP2D HeadlinesRecent News About These CompaniesMercedes C220 CDI W205 (2014) – Autobahn Acceleration POV | Diesel Beschleunigung Test DriveMay 13 at 12:38 AM | msn.comTrading Halt for Cardio Diagnostics (CDIO) Sparks Anticipation | CDIO Stock NewsMay 12 at 8:52 PM | gurufocus.comAnush Agarwalla Shines at Holtkamper Dressurtage Grand PrixMay 12 at 6:34 PM | devdiscourse.comCubic Defense: Cubic Digital Intelligence Expands TAKTICS Platform With New Intelligence Feeds for Enhanced Situational AwarenessMay 12 at 1:32 PM | finanznachrichten.deIndian Dressage Star Anush Agarwalla Shines with Personal Best at HoltkamperMay 12 at 1:32 PM | devdiscourse.comCubic Digital Intelligence Expands TAKTICS(TM) Platform With New Intelligence Feeds for Enhanced Situational AwarenessMay 12 at 1:32 PM | finance.yahoo.comMercedes C220 CDI BlueTec W205 | Autobahn Acceleration Kickdown Sound 🚗💨May 10 at 2:06 AM | msn.com45% Rate Hike on the Way for Pets Best Policyholders in California | InsurifyMay 9, 2025 | kpvi.comGQG Partners Updates Dividend Payment DetailsMay 9, 2025 | msn.comShed of the Week | Mercedes E320 CDI (W211)May 9, 2025 | pistonheads.comWales ‘Must Invest in Career Development’ to Meet its Potential in Key SectorsMay 8, 2025 | businessnewswales.comWith Boosts Projected at Ellis and Turfway, Kentucky Nearing Year-Round, Six-Figure MSW PursesMay 8, 2025 | thoroughbreddailynews.comCalifornia Dairies, Inc. Opens New Manufacturing FacilityMay 7, 2025 | foodengineeringmag.comBiotherapeutic Rebyota Prevents Recurrent CDI in Immunocompromised PatientsMay 7, 2025 | infectiousdiseaseadvisor.comCorp Fin Updates CDIs on Rule 10b5-1May 7, 2025 | jdsupra.comScientists engineer new drug candidate to fight deadly mycobacterial infectionMay 7, 2025 | msn.comLife360 Reports Decrease in CDIs for April 2025May 6, 2025 | tipranks.comStudy Challenges Long-Standing Safety Concerns With PPIsMay 6, 2025 | physiciansweekly.comPiedmont Lithium Reports Stable CDI Issuance for April 2025May 6, 2025 | tipranks.comResMed Inc Reports Changes in CDIs and Securities for April 2025May 5, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDP3D, AMED, CDI, and DP2D Company DescriptionsAmedisys NASDAQ:AMED$95.42 +0.11 (+0.12%) Closing price 05/12/2025 04:00 PM EasternExtended Trading$95.67 +0.25 (+0.27%) As of 04:03 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.CDI NYSE:CDICDI Corp. provides engineering, information technology and staffing solutions. The Company operates in three segments: Global Engineering and Technology Solutions (GETS), Professional Staffing Services (PSS) and Management Recruiters International (MRI). It provides staffing services through its MRINetwork of franchisees. The GETS segment provides engineering and information technology solutions that involve the production of deliverable work products or services performed at its facility or at a customer's facility. The PSS segment provides technical and professional personnel for discrete periods of time to augment the customer's workforce in times of project, seasonal, peak period or business cycle needs. The MRI segment is a global franchisor that does business as MRINetwork and provides the use of its trademarks, business systems and training and support services to its franchisees. It serves the oil, gas and chemicals, aerospace and industrial equipment, and hi-tech industries. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Latest Deal Could Put a Freeze on Its Stock Price A 90-Day Tariff Pause Sends Alibaba Flying—BlackRock Was Ready Why DraftKings Share Price Could Soar to Multi-Year Highs BP Buyout Buzz Puts Spotlight on Transocean’s Comeback Potential Here's Why Call Option Traders Love Dutch Bros Stock Can Shopify Stock Make a Comeback After an Earnings Sell-Off? MarketBeat Week in Review – 05/05 - 05/09 Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
